Identification of the possible therapeutic targets in the insulin-like growth factor 1 receptor pathway in a cohort of Egyptian hepatocellular carcinoma complicating chronic hepatitis C type 4

BACKGROUND: Molecular targeted drugs are the first line of treatment of advanced hepatocellular carcinoma (HCC) due to its chemo- and radioresistant nature. HCC has several well-documented etiologic factors that drive hepatocarcinogenesis through different molecular pathways. Currently, hepatitis C...

Descripción completa

Detalles Bibliográficos
Autores principales: Mabrouk, Nada M.K., Elkaffash, Dalal M., Abdel-Hadi, Mona, Abdelmoneim, Salah-ElDin, Saad ElDeen, Sameh, Gewaifel, Gihan, Elella, Khaled A., Osman, Maher, Baddour, Nahed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AboutScience 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7597224/
https://www.ncbi.nlm.nih.gov/pubmed/33132693
http://dx.doi.org/10.33393/dti.2020.1548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7597224/
https://www.ncbi.nlm.nih.gov/pubmed/33132693
http://dx.doi.org/10.33393/dti.2020.1548

Ejemplares similares